Doctor profile · Federal record
Dr. Karla Saint Andre, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Student in an Organized Health Care Education/Training Program · Pearland, TX
- NPI 1609261411
- 13 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
8520 Broadway St Ste 220
Pearland, TX 775847716
(713) 363-8600
fax (713) 363-7141 - Additional location
-
6431 Fannin St # 1.134
Houston, TX 770301501
(713) 500-6536 - Additional location
-
6550 Fannin St # Sm-1001
Houston, TX 770302717
(713) 441-6081
fax (713) 790-3026
Credentials & registration
- NPI registered
- March 2015 — 11 yrs on file
- Profile last updated
- August 19, 2020
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Texas #R9570
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609261411. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,949
Distinct HCPCS
10
Medicare allowed
$69,913
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,620 | 25 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 79 | 76 | $127 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 70 | 55 | $179 | |
96372 |
Injection of drug or substance under skin or into muscle | 46 | 29 | $14 | |
83036 |
Hemoglobin a1c level | 37 | 35 | $10 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 37 | 37 | $129 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 25 | 20 | $34 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 12 | 12 | $3 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 12 | 12 | $220 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 11 | 11 | $88 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 144. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$180
Transactions
4
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $100.85 | |
| Radius Health, Inc. | 1 | $49.54 | |
| IRONWOOD PHARMACEUTICALS, INC | 2 | $29.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,891
Patients
552
Total drug cost
$1,004,063
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Jardiance (Empagliflozin) | Brand | 281 | 61 | $256,640 |
| Levothyroxine Sodium | Generic | 218 | 79 | $3,294 |
| Ozempic (Semaglutide) | Brand | 206 | 58 | $304,594 |
| Pioglitazone Hcl | Generic | 164 | 43 | $2,049 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 151 | 57 | $2,270 |
| Metformin Hcl | Generic | 123 | 48 | $997 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 120 | 35 | $71,402 |
| Trulicity (Dulaglutide) | Brand | 103 | 26 | $139,406 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 100 | 24 | $89,267 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 83 | 23 | $36,074 |
Frequently asked questions
What is Dr. Karla Saint Andre's medical specialty?
Dr. Karla Saint Andre practices Endocrinology, Diabetes & Metabolism Physician in Pearland, TX.
Where does Dr. Karla Saint Andre practice?
Dr. Karla Saint Andre practices at 8520 Broadway St Ste 220, Pearland, TX 775847716. Office phone: 7133638600.
What is Dr. Karla Saint Andre's NPI?
Dr. Karla Saint Andre's National Provider Identifier (NPI) is 1609261411, issued by NPPES.
Does Dr. Karla Saint Andre accept Medicare assignment?
Dr. Karla Saint Andre does not accept Medicare assignment for all services. Patients may be billed amounts beyond Medicare-allowed charges.
What procedures does Dr. Karla Saint Andre commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215). Source: CMS Medicare Physician & Other Practitioners file.